Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

1.5K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

1.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.3K
Duplication of Chromatin Structure02:05

Duplication of Chromatin Structure

6.1K
The process of chromosome duplication during cell division requires genome-wide disruption and re-assembly of chromatin. The chromatin structure must be accurately inherited, reassembled, and maintained in the daughter cells to ensure lineage propagation.
The basic unit of the chromatin is the nucleosome, consisting of DNA wrapped around octameric histone proteins and short stretches of linker DNA separating individual nucleosomes. The histone proteins within the nucleosome have their...
6.1K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

6.0K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Postmitotic transcription and 3D regulation show locus-specific and differentiation-specific sensitivity to cohesin depletion.

Nature genetics·2026
Same author

Functional chromatin signatures premark future lineage-specific enhancers.

Cell genomics·2026
Same author

Feeder-free yet still naïve: improved method for capturing human pluripotent stem cells.

The EMBO journal·2026
Same author

Post-replicative chromatin accessibility predicts cell fate change.

Stem cell reports·2026
Same author

Morphomechanic tuning of ERK by actin-TFII-IΔ regulates cell identity.

bioRxiv : the preprint server for biology·2026
Same author

Modulation of Nudt21 levels reveals dose-dependent roles of alternative polyadenylation in tissue regeneration.

Nature communications·2026
Same journal

Six ways to put the public at the heart of science and policy.

Nature·2026
Same journal

The complex truth about trust in science.

Nature·2026
Same journal

Have people stopped trusting science? The data tell a surprising story.

Nature·2026
Same journal

How FAIR data are helping to build trust in science.

Nature·2026
Same journal

Scientists should recognize their own political biases to build public trust.

Nature·2026
Same journal

Harmonizing standards and resources for the medical genome.

Nature·2026
查看所有相关文章

相关实验视频

Updated: May 6, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K

在细胞重编程期间的染色质动态.

Effie Apostolou1, Konrad Hochedlinger

  • 11] Massachusetts General Hospital Center for Regenerative Medicine, 185 Cambridge Street, Boston, Massachusetts 02114, USA. [2] Harvard Stem Cell Institute, 1350 Masschusetts Avenue, Cambridge, Massachusetts 02138, USA. [3] Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, Maryland 20815, USA. [4] Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Medical School, 7 Divinity Avenue, Cambridge, Massachusetts 02138, USA.

Nature
|October 25, 2013
PubMed
概括
此摘要是机器生成的。

诱导多能性产生患者特异性的干细胞,并揭示了对转录因子和染色质结构的洞察力. 研究这些动态可能会促进再生医学和癌症治疗.

更多相关视频

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.1K
CRISPR-Mediated Reorganization of Chromatin Loop Structure
09:20

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

14.2K

相关实验视频

Last Updated: May 6, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.1K
CRISPR-Mediated Reorganization of Chromatin Loop Structure
09:20

CRISPR-Mediated Reorganization of Chromatin Loop Structure

Published on: September 14, 2018

14.2K

科学领域:

  • * 干细胞生物学和表观遗传学.
  • * 细胞命运决定的分子机制.

背景情况:

  • *诱导多能性 (iPSC) 技术使患者特定的干细胞产生.
  • * iPSC 技术提供了一个研究转录因子-染色质相互作用的模型.
  • * 了解染色体动态对于细胞状态转换至关重要.

研究的目的:

  • * 审查在诱导多能性期间的染色质动态的最新进展.
  • * 为了比较iPSC染色质事件与生殖细胞成熟和瘤发生.
  • * 探索再生医学和癌症治疗中的潜在应用.

主要方法:

  • *对诱导多能性和染色质动态的当前文献的综述.
  • *对iPSC,生殖细胞和瘤中的染色质重塑进行比较分析.
  • * 综合发现,提出综合机械学的见解.

主要成果:

  • * 染色体在诱导多能性时经历了显著的动态变化.
  • * 在多能性,生殖细胞发育和癌症的染色质重塑过程中存在相似之处.
  • * 这些动态色素事件是调节细胞命运的关键.

结论:

  • *诱导多能性为研究基本细胞生物学提供了有价值的框架.
  • * 综合了解不同过程中的染色质动态,可以产生新的治疗策略.
  • *进一步的研究可能会开启新的再生医学和癌症治疗方法.